Regulations & Compliance STREAM
-
Managing A Continually Evolving Disclosure Landscape
2/20/2024
Compliance is more important than ever. Keep up with how regions are enforcing disclosure requirements by learning how to adjust compliance strategies accordingly.
-
Plain Language Summaries Becoming A Mandate Worldwide
6/13/2024
A growing number of countries are requiring clinical trial protocol and results disclosures to be written in plain language, influencing how these documents are authored.
-
Reporting To ClinicalTrials.gov: Reflections And Challenges
11/7/2019
Who can reflect better on this topic than Dr. Deborah Zarin, former director of ClinicalTrials.gov? Dr. Zarin, now with the MRCT Center, shared her experiences and advice at the recent EXTRA: TrialScope Transparency Experience.
-
An Overview Of Health Canada's CTA Process
10/24/2023
Experience expedited timelines by conducting trials in Canada. Our expertise in navigating Health Canada's CTA process ensures smooth and efficient approvals.
-
TMF SUMMER SHORTS: House Of The Inspector
8/29/2024
Discover key steps you can take to not just survive an inspection, but take the TMF Throne.
-
Achieving Regulatory Compliance With A Unified Immunogenicity Strategy
5/10/2025
This presentation equips viewers with the knowledge and tools needed to navigate the intricacies of designing immunogenicity assays that comply with both European IVDR and US FDA regulations.
-
The Advantages Of Conducting Early Phase Trials In North America
10/24/2023
In this webinar, Altasciences discuss the similarities and differences of conducting early phase research in North America versus other geographic regions.
-
Preparing For 2022
1/19/2022
2022 will be an important year for drug development. There are many questions around changes that came into play during the pandemic. A panel of experts look back over the year and into the future to help you prepare for the coming year.
-
How Standardized Terminology Can Accelerate Global Regulatory Performance
6/24/2022
Watch this panel of regulatory experts taking part in an interactive roundtable examining the benefits of establishing standard terminology and its potential to help significantly improve regulatory quality, data accuracy, and efficiency.
-
Navigating The Unique Attributes Of Psychedelic Drug Development
1/22/2024
Join our panel of experts for an in-depth review of the FDA's guidance on psychedelic drug development, exploring necessary methodological adaptations for safety, pharmacology, and efficacy.